Our Blogs

• 10Dec2021

  AXA Guest Blog – Gene Editing – the biotech bringing new investment opportunities

  10Dec2021

  The coronavirus pandemic has made biotechnology front page news. The arrival of multiple vaccines in record time has starkly highlighted how innovative – and versatile – the sector can be.

  By Guest Blog

  Access Level | public

  Guest Blog

• 10Dec2021

  Outrageous Predictions for 2022 – Revolution

  10Dec2021

  Last week Saxo Bank released their “10 Outrageous Predictions for 2022”. These predictions are ‘unlikely’ events which could cause considerable disruption in markets, and are particularly relevant with the unpredictable COVID-19 crisis in mind.

  By Ben Debney

  Access Level | member

  Market commentary

• 10Dec2021

  2021 The Year Of Biotech

  10Dec2021

  In the last two years we have all become more appreciative of not just the work of our NHS, but also the extraordinary scientists who typically sit in the background. It is time for us to revisit the biotech funds.

  By Brian Dennehy

  Access Level | member

  Sector analysis

• 03Dec2021

  The Cautious Investor Conundrum – Cash Alternatives

  03Dec2021

  Stirring inflation, policy changes, COVID unlock, geo-political tensions… what does all of this mean for a typically cautious investor?

  By

  Access Level | member

  Market commentary

• 03Dec2021

  Global – Dynamic Portfolio Review

  03Dec2021

  This week we review our Dynamic Global Portfolio. We explore how the portfolio is made and its performance, both short term and long term.

  By Ben Debney

  Access Level | member

  Dynamic Portfolios

• 03Dec2021

  [Sector Edition] What’s Hot, What’s Not: UK & US Bonds Hot, Equities Not

  03Dec2021

  The big news over the last month was the emergence of a new COVID-19 variant – Omicron. The variant made its presence known across global markets, notably in the UK, Europe and US.

  By Ben Debney

  Access Level | member

  What's Hot What's Not

• 03Dec2021

  [Fund Edition] What’s Hot, What’s Not: Tech & UK Bonds Hot, Emerging Europe Not

  03Dec2021

  Half of the top 10 in November were Tech or UK Gilt funds, and the remainder of the hot funds were a real mixed bag. On the flipside, Emerging Europe, and a sprinkling of US small caps, have struggled.

  By Ben Debney

  Access Level | member

  What's Hot What's Not

• 26Nov2021

  Cut Out Noise. Now.

  26Nov2021

  With market volatility rising, and confidence waning, no more than ever you must cut out distractions. Noise reduction plays a vital role in your investment success in the long run, and protecting your capital in the short run.

  By Brian Dennehy

  Access Level | public

  Portfolio building

• 26Nov2021

  10 Steps To Survive A Market Downturn

  26Nov2021

  We talk a lot about ensuring you have a resilient investment plan that’s suitable for you. If you’ve been putting off writing that plan, now is an important time to act.

  By Ruairi Dennehy

  Access Level | member

  Portfolio building

• 19Nov2021

  World ex-UK – Dynamic Portfolio Review

  19Nov2021

  This week we review our Dynamic World ex-UK Portfolio. We explore how the portfolio is made and its performance, both short term and long term.

  By Ben Debney

  Access Level | member

  Dynamic Portfolios

• <<
• <
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• 41
• >
• >>